Biguanides Market to Expand at 6.8% CAGR, Growing from $2.5 Billion in 2023 to $4.9 Billion by 2033.
Biguanides Market revolves around a class of drugs commonly used to treat type 2 diabetes by reducing blood sugar levels. Biguanides, including metformin, work by …